DENVER, Nov. 2, 2016 /PRNewswire/ — MassRoots, Inc. (MSRT), one of the leading technology platforms for the cannabis industry, is pleased to announce that it has released product and strain reviews within its iOS and Android applications. Through community-driven reviews, MassRoots aims to connect consumers with the best products to treat their ailments.

“There are currently tens of thousands of strains and products in the regulated cannabis industry, making it difficult for consumers to find the best ones to treat their ailments, such as back-pain or nausea,” stated MassRoots CEO Isaac Dietrich. “Through community-driven reviews, we’re enabling our passionate user base to easily provide this information and then present it in a meaningful way for everyday people to make cannabis purchasing decisions.”

MassRoots is accessible in every state with a medicinal or recreational cannabis law. On November 8, 2016, nine states will be voting on initiatives to regulate the production and sale of cannabis, potentially expanding the regulated cannabis market from around $7 billion in 2016 to more than $23 billion by 2020 according to ArcView Market Research. MassRoots expects the continued addition of new features to its platform combined with expansion of the regulated cannabis market could significantly accelerate its user growth and potential revenues.

About MassRoots
MassRoots is one of the largest technology platforms for the regulated cannabis industry. It is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots has been covered by The Hill, Denver Post, Fortune, Forbes, and CNBC. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
  1. I bought weedmaps and tried to sell .My price order was hit and passed over and the price was passed over for weeks. I set the price for a loss and it instantly traded. I will never buy a weed tech stock or penny stock again

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer…